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Reciprocal balanced translocations associated with clinical features 
are very rare. This study reports cytogenetic and molecular cytogenetic 
findings in a 3-yr-old female patient with mild developmental retardation, 
slight hypotone with a de novo balanced 46, XX, t(2; 11) (q33; q23) 
translocation. Her parent attended private office at Tehran, Iran in 2013. 
G-banded chromosomes and FISH-Analysis were used to examine the 
patient’s karyotype as well as her parents. FISH-probes prepared with 
specific RP11-BAC clones mapped near 2q33 and 11q23 regions were 
used to characterize the location of the breakpoints. One of the break 
points is located within the human NBEAL1-Gene locus on chromosome 
2, suggesting a correlation between this gene disruption and the patient’s 
mild developmental retardation. 
Keywords: Balanced translocation; NBEAL1-Gene, ALS2-gene; ALS; 
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Introduction
The Amyotrophic lateral sclerosis (ASL) is a progressive, neurodegenerative 
disease causing functionless of the motor upper neurons in the brain and lower 
motor neurons of the spinal cord systems and finally death from respiratory 
failure, usually within 3 to 5 yr of symptom onset. Over 90% of ALS are sporadic. 
Totally, 5%-10% is familial amyotrophic lateral sclerosis (FALS) but clinically 
indistinguishable from the sporadic form of the disease (1). Despite numerous 
efforts in the last decade, the basic pathophysiology of ALS remains unclear. 
Familial amyotrophic lateral sclerosis (FALS) is inherited as either autosomal 
dominant or autosomal recessive pattern. Recessive forms of ALS usually 
have juvenile onset. About 20% of FALS occur because of mutation found on 
SOD1 gene, but the causes of about 80% of adult-onset dominantly inherited 
FALS are not clear yet (2). One of the genes located on the critical region of 
type two ALS is NBEAL1 gene (ALS2CR17; Amyotrophic lateral sclerosis 2 
chromosomal region candidate gene 17 proteins). The NBEAL1-Gene is a novel 
human neurobeachin-like 1 protein gene located on the chromosome two (2q33.2) 
and belongs to candidate genes for lateral sclerosis 2 (ALS2) with 25 Exons and 
two Beige/BEACH domains and 3 WD40 repeats. NBEAL1 gene spans about 
73 kb of genomic DNA. The RT-PCR results showed that NBEAL1 is expressed 
mostly in the human brain, kidney, prostate, and testis. The significant rate of 
NBEAL1 gene expression in gliomas, compared to normal brain tissue, suggests 
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normal phenotype (5). 
The current study was an attempt to map the exact 
breakpoint on chromosome number two and eleven and 
to nominate and characterize the disrupted genes and 
their correlation with clinical findings on this patient.
Case Report
The case is a 3 yr old girl with mild developmental 
delay. Parents referred to private physicians’ clinics 
since the mother was over 35 during pregnancy in 
Tehran, Iran in 2013. The result of amniocentesis 
showed a balanced translocation in fetus with no other 
findings in ultrasound scans (46, XX, t(2; 11) (q33; 
q23) (Figure 1). Parents’ karyotypes were normal. 
After birth, the baby girl did not show any major or 
minor clinical anomalies and therefore was discharged 
from the hospital. After 3 yr, the girl showed some mild 
developmental delays, therefore, referred for further 
genetic analysis. Informed consent was taken from the 
parents.
a correlation with gliomas (3). However, there are no 
reported cases indicating the fact that, disruption of 
this gene could yield clinical phenotype. Although 
one of the causes of the gene disruption in neonates 
is autosomal reciprocal translocations, the frequency 
of this sort of translocation is very low (0.1%) (4). 
The majority of balanced translocations (96%) are 
not associated with clinical features (3). This is due to 
either translocation disrupting non-coding regions of 
genome or breakpoint is not on dose sensitive genes. 
Therefore, characterization of the genetic causes of the 
cases with de novo balanced translocation and clinical 
features is still favoured and followed by researchers, 
which could help to understand correlation mechanism 
of patient genotype and phenotype.
If carrier parent have a balanced rearrangement 
their offspring is in majority case normal. The risk 
for phenotypic abnormality is generally very low. 
Nonetheless, there are several reports for balanced 
translocation people with abnormal phenotypes, who 
has parent with the same balanced chromosomes but 
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Fig 1. High-resolution GTG banding showed a reciprocal balanced translocation t(2;11)(q33.2;q23.2) in the fetus.  
1a: Translocated chromosomes 2 and 11.  2 b: Normal chromosomes 2 and 11
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Peripheral blood was collected for karyotype and DNA 
extraction. This procedure was carried out for both 
parents too. After locating, the primary breakpoint 
region in chromosome number two and eleven by high-
resolution karyotype methods, 30 BACs clones were 
ordered for further analysis of the regions and then 21 
was used for mapping the breakpoint.
Preparing Locus Specific probes
Chromosome preparations and high-resolution 
chromosomes were made from peripheral blood of the 
patient and her parents using standard methods. In order 
to map the breakpoint on the chromosome 2q33 and 
11q23 regions, the following BACs (bacterial artificial 
chromosome) were ordered based on the information 
obtained from the genome browser part of http://
genome.ucsc.edu/ (Table1).
Table 1. Used BACs, their position, and character
Name Chromosome Start End Length (kb) Band
RP11-265N15 2 200002213 200178128 175.916 2q33.1
RP11-984A14 2 201531144 201699319 168.176 2q33.1
RP11-61B5 2 202446118 202606502 160.385 2q33.1
RP11-951H20 2 202897953 203067146 169.194 2q33.1
RP11-164J9 2 203452370 203611753 159.384 2q33.1-
2q33.2
RP11-96E8 2 203558342 203715728 157.387 2q33.2
RP11-1133F11 2 203658771 203809833 151.063 2q33.2
RP11-771C13 2 203758666 203939481 180.816 2q33.2
RP11-963F8 2 203804972 204003029 198.058 2q33.2
RP11-916F5 2 208636277 208823743 187.467 2q33.3
RP11-14M16 11 112546742 112704340 157.599 11q23.1
RP11-1146P22 11 113500406 113657059 156.654 11q23.2
RP11-584C22 11 114601776 114812896 211.121 11q23.2
RP11-521L22 11 114820119 114986617 166.499 11q23.2
RP11-698I1 11 114914151 115091089 176.939 11q23.2
RP11-158B3 11 115064956 115220235 155.280 11q23.2
RP11-822K7 11 115141419 115327772 186.354 11q23.3
RP11-1081G12 11 114385681 114608391 222.711 11q23.2
RP11-984C17 11 115326382 115523057 196.676 11q23.2-
11q23.3
RP11-2020 11 116250688 116416874 166.187 11q23.3
RP11-764D19 11 116994343 117176849 182.507 11q23.3
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BACs DNA was labeled by Nick-Translation method 
using digoxigenin 11-dUTP (Roche) and Biotin 
(Invitrogen). DNA hybridization was performed as 
described in standard protocols. FISH slides were 
analyzed using a Zeiss Axioskop microscope with a 
cooled charged-coupled-device camera (Photometric) 
and then Imaging Meta system software was applied.
Aminocytic analysis revealed a balanced translocation 
t (2q;11q) in the fetus. The mapping of breakpoint was 
carried out using locus-specific FISH probes (LSP) 
made on with about 21 BACs clones. All the selected 
FISH probes were hybridized with the long arm of 
chromosome number two except FISH probes made on 
BACs RP11-771C13, RP11-963F8, and RP11-916F5 
that hybridized with long arm of chromosome 11. In 
addition, hybridization of BACs RP11-113FI1 was 
positive, but its signal was divided into two regions in 
the band 2q33.2 and chromosome 11. In chromosome 
number 11, all probes were hybridized and signals 
were obvious except for BACs probes RP11-158B3, 
Rp11-822K7, Rp11-984C17 and Rp11-2020 that 
hybridized with long arm of chromosome number 2. 
Rp11-69811signals was divided between long arm of 
chromosome number 2 and 11 (Figure 2). 
Discussion
More than 90% of the de novo balanced translocation 
has no clinical impact since it occurs in the non-coding 
region of the genome or disrupts non-dose dependent 
genes. In the current study, a baby girl came to attention 
since she had mild developmental delay. Although her 
balanced translocation was noticed during her fetal 
period, her parents did not show any interest for further 
examination until she becomes 3 yr old and showed 
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Fig 2. FISH signals in metaphase and interphase from peripheral blood and a combination of two FISH-probes from split BACs 
(SB). The split BAC of chromosome 2q (RP11-1133F11) was red labeled and the split BAC of chromosome 11q (RP11-698I1) 
was green labeled. In normal chromatid, only one signal either green (on Chr. 2) or red (on Chr. 11) were detected. In chromatid 
with translocation, two signals (Red/Green) or their combination (yellow) was detected. N=normal, T=translocated
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some symptoms. When locus-specific identifier (LSI) 
probes were designed to map the breakpoint between 
bands 2q33.1 and 2q33.3, all probes were hybridized, 
except the probe made from BAC RP11-771C13, RP11-
963F8 and RP11-916F5 that hybridized with long arm 
of chromosome 11. In addition, hybridization of BAC 
RP11-113F11 was positive, but its signal was divided 
into two regions in the band 2q33.2 and chromosome 
11. This clone contains about 157kb of chromosome 
2q33.2 band. The clone start point is from 203558342bp 
and end is 203715728bp. When the LSI probe (Rp11-
771C13) in the only 42938bp (about 43kb) downstream 
of this clone was used for hybridization purpose, FISH 
signal was negative on chromosome 2 but has positive 
signal on chromosome 11. Rp11-771C13 started from 
203758666bp and ended in 203939481bp on the band 
2q33.2. In the next step, the researcher chose an LSI probe 
that overlapped the distal part of Rp11-96E8 BAC and 
the proximal part of Rp11-771C13 BAC, in addition to 
covering 43 kb gap between these two probes. The start 
and end of the BAC Rp11-113F11 were 203658771-
203809833bp, respectively. This probe was hybridized 
but its signals were divided between long arms of 
chromosome number 2 and 11. The Rp11-113F11 BAC 
probe signal may indicate that this signal was related to 
the 43 kb distance between these two BACs Rp11-96E8 
and RP11-771C13 (Figure 3).
Fig 3. Some of the BACs clones were used for mapping the breakpoint region on chromosome 2 and how RP11-1133F11 probe 
overlap with NBEAL1 gene. NT=Not translocated, T=Translocated, SB=Spilt BACs
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The application of blast for the sequence spanned in 
this 43kb region indicated that NBEAL1 gene was 
located in this region. It was for the first time that a 
correlation with the disruption of NBEAL1 gene and its 
consequence was shown. Unfortunately, after reporting 
this finding to the parents of the patient, they did not 
show interest for further cooperation and, consequently, 
it was not possible to sequence the NBEAL1 gene in 
the patient for its further analysis to identify its exact 
disruption point. 
In order to evaluate the breakpoint region on the long 
arm of chromosome 11 (11q23.2 band), among all 
used FISH probes only probe on BACs RP11-158B3, 
Rp11-822K7, Rp11-984C17, and Rp11-2020 did not 
hybridize with the expected region on chromosome 11 
and instead hybridized with long arm of chromosome 
number 2. Rp11-69811 signals were divided between 
long arm of chromosome number 2 and 11Rp11-
698I1. The start point of the BAC 114914151bp and 
the end is 115091089bp (176939bp). When this region 
sequence was blasted, no coding sequence was found 
which means this deletion is in the non-coding region 
of chromosome number 11 and has no effect on and 
contribution to the observed patient symptoms. 
In conclusion, despite this fact that more than 90% of the 
de novo balanced translocation has no clinical impact, 
in this special case it was shown that the phenotype of 
patient is because of her disrupted NBEAL1 gene. 
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